Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how? (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(23)00112-x
PubMed Identifier: 37329893
Publication URI: http://europepmc.org/abstract/MED/37329893
Type: Journal Article/Review
Volume: 4
Parent Publication: The Lancet. Microbe
Issue: 8
ISSN: 2666-5247